What is it about?
In the era of multi-drug resistance bacteria, the cost in hospitalization usually is high because long bed-day use. in some patients (without shock, or other systemic complications) the outpatient antimicrobial therapy it is effective for a long therm antibiotic use. Ertapenem is a formulation that allows one day use, full cover cor ESBL rods, and cost effective
Featured Image
Why is it important?
We encourage to increase these kind of programs for MDR infections
Perspectives
I believe that there is a way to improve the use of antimicrobials, and with this article we proved that this actions can save and controlled better infections without the implications to be hospitalized
Daniel Aguilar-Zapata
Medica Sur SA de CV
Read the Original
This page is a summary of: Outpatient ertapenem therapy in an ESBL-high-prevalence area: an efficacy, safety, and cost study, Infection and Drug Resistance, December 2018, Dove Medical Press,
DOI: 10.2147/idr.s173468.
You can read the full text:
Contributors
The following have contributed to this page
